国际标准期刊号: 2469-9764

工业化学:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 学者指导
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
分享此页面

抽象的

Encapsulation of Ibuprofen into Solid Lipid Nanoparticles for Controlled and Sustained Release using Emulsification Solvent Evaporation Technique- Wesley N Omwoyo- University-Vaal University of Technology

Wesley N Omwoyo

Statement of the Problem:

Ibuprofen (IBU) is widely used Non-steroidal Anti-inflammatory Drug (NSAID), analgesic and antipyretic agent. It has poor aqueous solubility leading to low oral absorption leading to bio inequivalence problem and frequent dosing causing patient non-compliance. Improving the aqueous solubility has been reported to increase drug absorption which ensures quick onset of pharmacological actions. To actualize this, IBU was nano-formulated into solid lipid nanoparticles to reduce the drug particle size thus enlarging the surface area.

Aim: This approach is effective in speeding up dissolution, increasing oral absorption and achieving sustained and controlled release of the drug from the nanocarrier.

IBU loaded nanoparticles were prepared by emulsification solvent evaporation technique and characterized by Fourier transform infrared spectroscopy, thermogravimetric analysis, X-ray diffraction and transmission electron microscopy. Release kinetics on the drug loaded nanoparticles was carried out in phosphate buffer pH 6.8 using pharma test dissolution apparatus adopting shaking basket method at 37 °C. The optimized IBU-loaded SLNs had a particle size of 76.40 nm, polydispersity index of 0.275 and zeta potential of -41.3 mV. The encapsulation efficiency and drug loading were 99.73% and 2.31% respectively. The FTIR spectra confirmed successful encapsulation of the drug inside the nanocarrier as only peaks responsible for the emulsifier and the binder could be identified. This corroborated well with XRD spectra which showed a completely amorphous state of the drug loaded nanoparticles as compared to the crystalline nature of pure drug. The IBU-SLNs showed a release profile of up to eight hours which is a great improvement from other reported works.

Findings:  The release data obtained was quantitatively correlated with several mathematical models. The drug release pattern of IBU-SLNs was best fitted with Higuchi square root model and followed Higuchi drug release kinetics. Korsmeyer-Peppas model confirmed a non-fickian diffusion model for the release of the drug from the matrix system.

 

 

Note: This work was presented in Frontiers in Nanotechnology and Nanomaterials, which was scheduled in May 04-05, 2020 at Vienna, Austria.